U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07192458) titled 'High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)' on Sept. 17.
Brief Summary: This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center.
Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients...